Triamcinolone acetonide - Generic Drug Details

What are the generic drug sources for triamcinolone acetonide and what is the scope of patent protection?

Triamcinolone acetonide is the generic ingredient in twenty-seven branded drugs marketed by Abbvie, Chattem Sanofi, Astellas, Ivax Pharms, Delcor Asset Corp, Teva, Solvay, Actavis Mid Atlantic, Alkem Labs Ltd, Alpharma Us Pharms, Ambix, Cosette, Encube, Fougera Pharms, Glenmark Pharms Ltd, Lupin, Macleods Pharms Ltd, Micro Labs, Morton Grove, Mylan, Padagis Us, Pharmaderm, Pharmafair, Strides Pharma, Taro, Taro Pharm Inds Ltd, Topiderm, Crown Labs, Savage Labs, Pacira Pharms Inc, Apothecon, Amneal, Eugia Pharma, Long Grove Pharms, Mylan Labs Ltd, Parnell, Sandoz Inc, Teva Pharms Usa, Watson Labs, Allergan, Novartis, Akorn, Pai Holdings Pharm, Quagen, Wockhardt Bio Ag, Cintex Svcs, Glenmark Pharms, Novel Labs Inc, Padagis Israel, Cmp Pharma Inc, Lyne, Lupin Atlantis, Sanofi Aventis Us, Perrigo Pharma Intl, Sun Pharm Inds Inc, Rising, and Bausch And Lomb Inc, and is included in one hundred and thirty-five NDAs. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Triamcinolone acetonide has one hundred and fifty-two patent family members in twenty-nine countries.

There are twenty-six drug master file entries for triamcinolone acetonide. Sixty-five suppliers are listed for this compound.

Summary for triamcinolone acetonide

International Patents:	152
US Patents:	7
Tradenames:	27
Applicants:	57
NDAs:	135
Drug Master File Entries:	26
Finished Product Suppliers / Packagers:	65
Raw Ingredient (Bulk) Api Vendors:	75
Clinical Trials:	248
Patent Applications:	7,039
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for triamcinolone acetonide
Drug Sales Revenues:	Drug sales revenues for triamcinolone acetonide
What excipients (inactive ingredients) are in triamcinolone acetonide?	triamcinolone acetonide excipients list
DailyMed Link:	triamcinolone acetonide at DailyMed

See drug prices for triamcinolone acetonide

See drug sales revenues for triamcinolone acetonide

Recent Clinical Trials for triamcinolone acetonide

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Kartal City Hospital	N/A
University of Southern California	Early Phase 1
Oxular Limited	Phase 2

See all triamcinolone acetonide clinical trials

Pharmacology for triamcinolone acetonide

Drug Class	Corticosteroid
Mechanism of Action	Corticosteroid Hormone Receptor Agonists

Medical Subject Heading (MeSH) Categories for triamcinolone acetonide

Anti-Inflammatory Agents

Glucocorticoids

Immunosuppressive Agents

US Patents and Regulatory Information for triamcinolone acetonide

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Taro Pharm Inds Ltd	TRIAMCINOLONE ACETONIDE	triamcinolone acetonide	OINTMENT;TOPICAL	040037-001	Sep 30, 1994	AT	RX	No	No
Sun Pharm Inds Inc	KENALOG	triamcinolone acetonide	SPRAY;TOPICAL	012104-001	Approved Prior to Jan 1, 1982	AT	RX	Yes	Yes
Astellas	ARISTOCORT	triamcinolone acetonide	OINTMENT;TOPICAL	080750-004	Approved Prior to Jan 1, 1982		DISCN	No	No
Teva	TRIACET	triamcinolone acetonide	CREAM;TOPICAL	084908-002	Approved Prior to Jan 1, 1982		DISCN	No	No

Expired US Patents for triamcinolone acetonide

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Novartis	TRIESENCE	triamcinolone acetonide	INJECTABLE;INTRAVITREAL	022048-001	Nov 29, 2007
Abbvie	AZMACORT	triamcinolone acetonide	AEROSOL, METERED;INHALATION	018117-001	Apr 23, 1982
Chattem Sanofi	NASACORT ALLERGY 24 HOUR	triamcinolone acetonide	SPRAY, METERED;NASAL	020468-002	Oct 11, 2013
Chattem Sanofi	NASACORT ALLERGY 24 HOUR	triamcinolone acetonide	SPRAY, METERED;NASAL	020468-002	Oct 11, 2013

International Patents for triamcinolone acetonide

Country	Patent Number	Title	Estimated Expiration
South Korea	20160005735	안구용 주사를 위한 장치 및 방법 (APPARATUS AND METHODS FOR OCULAR INJECTION)
Chile	2013000347	Poblacion de microparticulas que comprenden un corticoesteroide clase b incorporado en una matriz formada por un copolimero de acido lactico y acido glicolico, donde dicho corticoesteroide comprende entre 22% a 28% de las microparticulas; preparacion de liberacion controlada; formulacion; y metodo de fabricacion.
Japan	5581227
Israel	222638	התקנים למתן תרופה לרקמה עינית על ידי מיקורמחט ותכשירים עבורם (Devices for drug delivery to ocular tissue comprising a microneedle and compositions for use therein)